Literature DB >> 24365128

Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.

Yan Li1, Qiang Cheng2, Qian Jiang2, Yuanyu Huang2, Hongmei Liu1, Yuliang Zhao3, Weipeng Cao3, Guanghui Ma4, Fengying Dai5, Xingjie Liang6, Zicai Liang7, Xin Zhang8.   

Abstract

Cationic liposome based siRNA delivery system has improved the efficiencies of siRNA. However, cationic liposomes are prone to be rapidly cleared by the reticuloendothelial system (RES). Although modification of cationic liposomes with polyethylene glycol (PEG) could prolong circulation lifetime, PEG significantly inhibits siRNA entrapment efficiency, cellular uptake and endosomal/lysosomal escape process, resulting in low gene silencing efficiency of siRNA. In this study, we report the synthesis of zwitterionic polycarboxybetaine (PCB) based distearoyl phosphoethanolamine-polycarboxybetaine (DSPE-PCB) lipid for cationic liposome modification. The DSPE-PCB20 cationic liposome/siRNA complexes (lipoplexes) show an excellent stability in serum medium. The siRNA encapsulation efficiency of DSPE-PCB20 lipoplexes could reach 92% at N/P ratio of 20/1, but only 73% for DSPE-PEG lipoplexes. The zeta potential of DSPE-PCB20 lipoplexes is 8.19±0.53mV at pH 7.4, and increases to 24.6±0.87mV when the pH value is decreased to 4.5, which promotes the endosomal/lysosomal escape of siRNA. The DSPE-PCB20 modification could enhance the silencing efficiency of siRNA by approximately 20% over the DSPE-PEG 2000 lipoplexes at the same N/P ratio in vitro. Furthermore, DSPE-PCB20 lipoplexes could efficiently mediate the down-regulation of Apolipoprotein B (ApoB) mRNA in the liver and consequently decrease the total cholesterol in the serum in vivo, suggesting therapeutic potentials for siRNA delivery in hypercholesterolemia-related diseases.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cationic liposomes; Endosomal/lysosomal escape; Polycarboxybetaine; pH-sensitive; siRNA delivery

Mesh:

Substances:

Year:  2013        PMID: 24365128     DOI: 10.1016/j.jconrel.2013.12.007

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  21 in total

1.  Therapeutic silencing of mTOR by systemically administered siRNA-loaded neutral liposomal nanoparticles inhibits DMBA-induced mammary carcinogenesis.

Authors:  Roja Sahu; Shakti Prasad Pattanayak; Shivesh Jha
Journal:  Br J Cancer       Date:  2022-10-19       Impact factor: 9.075

Review 2.  Strategies for improving drug delivery: nanocarriers and microenvironmental priming.

Authors:  Ayesha Khalid; Stefano Persano; Haifa Shen; Yuliang Zhao; Elvin Blanco; Mauro Ferrari; Joy Wolfram
Journal:  Expert Opin Drug Deliv       Date:  2016-10-11       Impact factor: 6.648

3.  Zwitterionic Phospholipidation of Cationic Polymers Facilitates Systemic mRNA Delivery to Spleen and Lymph Nodes.

Authors:  Shuai Liu; Xu Wang; Xueliang Yu; Qiang Cheng; Lindsay T Johnson; Sumanta Chatterjee; Di Zhang; Sang M Lee; Yehui Sun; Ting-Chih Lin; John L Liu; Daniel J Siegwart
Journal:  J Am Chem Soc       Date:  2021-12-08       Impact factor: 16.383

4.  Zwitterionic poly(carboxybetaine)-based cationic liposomes for effective delivery of small interfering RNA therapeutics without accelerated blood clearance phenomenon.

Authors:  Yan Li; Ruiyuan Liu; Yuanjie Shi; Zhenzhong Zhang; Xin Zhang
Journal:  Theranostics       Date:  2015-02-27       Impact factor: 11.556

5.  Mono-arginine Cholesterol-based Small Lipid Nanoparticles as a Systemic siRNA Delivery Platform for Effective Cancer Therapy.

Authors:  Jinju Lee; Phei Er Saw; Vipul Gujrati; Yonghyun Lee; Hyungjun Kim; Sukmo Kang; Minsuk Choi; Jae-Il Kim; Sangyong Jon
Journal:  Theranostics       Date:  2016-01-01       Impact factor: 11.556

6.  siRNA-loaded poly(histidine-arginine)6-modified chitosan nanoparticle with enhanced cell-penetrating and endosomal escape capacities for suppressing breast tumor metastasis.

Authors:  Ping Sun; Wei Huang; Lin Kang; Mingji Jin; Bo Fan; Hongyan Jin; Qi-Ming Wang; Zhonggao Gao
Journal:  Int J Nanomedicine       Date:  2017-04-19

7.  Precise Photodynamic Therapy of Cancer via Subcellular Dynamic Tracing of Dual-loaded Upconversion Nanophotosensitizers.

Authors:  Yulei Chang; Xiaodan Li; Li Zhang; Lu Xia; Xiaomin Liu; Cuixia Li; Youlin Zhang; Langping Tu; Bin Xue; Huiying Zhao; Hong Zhang; Xianggui Kong
Journal:  Sci Rep       Date:  2017-03-31       Impact factor: 4.379

Review 8.  Drug carriers based on highly protein-resistant materials for prolonged in vivo circulation time.

Authors:  Ruiyuan Liu; Yan Li; Zhenzhong Zhang; Xin Zhang
Journal:  Regen Biomater       Date:  2015-05-21

9.  Antibody h-R3-dendrimer mediated siRNA has excellent endosomal escape and tumor targeted delivery ability, and represents efficient siPLK1 silencing and inhibition of cell proliferation, migration and invasion.

Authors:  Jun Li; Jing Liu; Shengnan Li; Yanli Hao; Lei Chen; Xiaoning Zhang
Journal:  Oncotarget       Date:  2016-03-22

10.  Anti-EphA10 antibody-conjugated pH-sensitive liposomes for specific intracellular delivery of siRNA.

Authors:  Xinlong Zang; Huaiwei Ding; Xiufeng Zhao; Xiaowei Li; Zhouqi Du; Haiyang Hu; Mingxi Qiao; Dawei Chen; Yuihui Deng; Xiuli Zhao
Journal:  Int J Nanomedicine       Date:  2016-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.